Oramed Pharmaceuticals (FRA:OJU1) Float Percentage Of Total Shares Outstanding: 84.51% (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OJU1 Oramed Pharmaceuticals Inc FRA:OJU1
32 GF Score
Price €3.43
! 4 Warning Signs
View Full Analysis

What is Oramed Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Oramed Pharmaceuticals FRA:OJU1 -4.99% 32 Float Percentage Of Total Shares Outstanding is 84.51% as of Jul. 31, 2026. GuruFocus rates FRA:OJU1 with a GF Score™ of 32/100. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Oramed Pharmaceuticals's float shares is 34.59 Mil. Oramed Pharmaceuticals's total shares outstanding is 40.93 Mil. Oramed Pharmaceuticals's float percentage of total shares outstanding is 84.51%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Oramed Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Oramed Pharmaceuticals's Institutional Ownership is 7.44%.

FRA:OJU1
32GF Score
Oramed Pharmaceuticals Inc FRA:OJU1
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oramed Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Oramed Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=34.59/40.93
=84.51%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 84.51% mean?
Oramed Pharmaceuticals (FRA:OJU1) has a Float Percentage Of Total Shares Outstanding of 84.51% as of Jul. 31, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Oramed Pharmaceuticals and its competitors.
Is Oramed Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
Oramed Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 84.51%. Overall, Oramed Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Oramed Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to CAMP and PYXS?
Oramed Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 84.51% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Oramed Pharmaceuticals and its competitors. Oramed Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 84.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oramed Pharmaceuticals stock overvalued right now?
Oramed Pharmaceuticals (FRA:OJU1) has a current Float Percentage Of Total Shares Outstanding of 84.51%. The current Float Percentage Of Total Shares Outstanding is 84.51%. Oramed Pharmaceuticals' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Oramed Pharmaceuticals (FRA:OJU1), the current Float Percentage Of Total Shares Outstanding is 84.51% as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oramed Pharmaceuticals Business Description

Address 1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
32GF Score

Get the complete analysis for FRA:OJU1

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.43
Price